The Valley Desk

NCT00686075 · Interventional trial

A Study to Evaluate the Safety, Tolerability, Immunogenicity and Vaccine-like Viral Shedding of MEDI-534, Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy 6 to <24 Month-old Children and in 2 Month-old Infants

Overall registry status Completed

Phase 1 · Phase 2

Conditions Healthy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov